Michael WY Chan

Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer

Jian‐Liang Chou, Her‐Young Su, Lin‐Yu Chen et al. · Laboratory Investigation · 2010 · 115 citations · Full text

Medicine, Molecular Genetics, Oncology +17

An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules

Huaxia Qin, Michael WY Chan, Sandya Liyanarachchi et al. · BMC Systems Biology · 2009 · 66 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +17

Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine

Pi-Che Chen, Ming‐Hsuan Tsai, Sidney KH Yip et al. · BMC Medical Genomics · 2011 · 45 citations · Full text

Medicine, Genetics, Oncology +17

Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma

Pao‐Ling Torng, Ching‐Wei Lin, Michael WY Chan et al. · Molecular Cancer · 2009 · 41 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target

Lin‐Yu Chen, Rui Huang, Michael WY Chan et al. · The Journal of Pathology · 2019 · 37 citations · Full text

Medicine, Cancer Biology, Molecular Biology +17